National Market Access Lead - Immunology

Apply now

Date: Jun 5, 2019

Location: Slough, Berkshire, GB

National Market Access Lead
UCB – Inspired by patients. Driven by science
Help us transform patients’ lives

About UCB

At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talent makes the most of who they are, unlocking innovation and setting new standards for patients.

Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.

To strengthen our National Market Access Group, we are looking to fill the position of: National Market Access Lead – Immunology.

 

What We Offer
An opportunity to:

  • Be supported to flourish in this high performing culture, where patients are at the heart of what drives our decision making.
  • Be empowered and developed through exposure to an integrated business approach, you will have the opportunity to work collaboratively with Global, European and affiliate experts.
  • Have a diverse portfolio and be driven by world leading science, patient access to our innovative medicines is a priority at UCB.
  • Drive the development of innovative and implementable access tools, solutions and frameworks
     

About the Role
You will be responsible for:

  • Leading, and developing clear and commercially driven Market Access strategies and HTA submission by utilising stakeholder insights and on trend market knowledge of health economics.
  • Being the face of UCB for all external HTA communications including representation at committee meetings.
  • Developing and executing high quality Pricing & Reimbursement strategies and HTA submissions for the UK & Ireland.
  • Leading key consultations, shaping and inputting into National clinical guideline reviews, therapeutic consultations, quality standards and competitor consultations.
  • Supporting UCB's Market Access capability and being the internal expert on the reimbursement environment and share knowledge; being the expert on HTA policies and methodologies.
  • Leading on national HTA submissions; optimising national clinical guidelines reviews, therapeutic consultations, quality standards and competitor consultations regional business case submissions.
  • Developing an external network with leaders in the field of Health Economics and P&R, driving customer insight on current and future clinical practice to inform national HTA submissions.
  • Collaborating to ensure robust project plans are developed with clear expectation of deliverables and responsibilities.
  • Building productive working partnerships with Global and European Market Access pricing teams to develop pricing strategies and commercial schemes.
     

About You
You should have:

  • MSc or PhD in Health Economics (or equivalent).
  • Substantial Health Economics experience within the Pharmaceutical Industry and previous market or market access experience.
  • Demonstrable ability to plan at a business unit level of complexity and a marketing programmes
  • Expert knowledge of NHS structures, processes and policies, decision making networks and understanding of therapy areas.
  • Strong knowledge of the UK political and healthcare policy environment and experience of Health Economic Submissions.
  • Experience having written HTA submissions, applying to NICE and being successful. 
     

UCB – The Facts
With more than 7500 employees in approximately 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work:

  • Promising pipeline that includes several novel molecules and no major patent expiration in the next decade;
  • About 25% of 2016 revenue reinvested into Research & Development
  • 2016 Key Financials: €4.2 billion global revenue Specialties: Neurology, Immunology


Job Segment: Neurology, Immunology, Pharmaceutical, Patent, Healthcare, Science, Research, Legal

Apply now